Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag

Vaccine. 2007 Jan 4;25(2):253-63. doi: 10.1016/j.vaccine.2006.07.034. Epub 2006 Aug 4.

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent immunomodulatory cytokine. Here we generated a novel codon-optimized murine GM-CSF gene as an adjuvant. The codon-optimized GM-CSF gene significantly increased protein expression levels in all cells tested. Although injection of the wild-type GM-CSF plasmids adjuvanted HIV-1 Gag DNA vaccine induced detectable immune responses, co-administration of plasmids encoding the codon-optimized GM-CSF sequence with the DNA vaccine resulted in a strong antibody and CTL responses and a protective immune response against infection with recombinant vaccinia virus expressing HIV-1 Gag. This novel codon-optimized GM-CSF gene offers a practical molecular strategy for potentiating immune responses to vaccines as well as other immunotherapeutic strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / immunology*
  • Adjuvants, Immunologic / pharmacology*
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • COS Cells
  • Chlorocebus aethiops
  • Codon*
  • Cytokines / analysis
  • Female
  • Flow Cytometry
  • Gene Products, gag / immunology*
  • Granulocyte-Macrophage Colony-Stimulating Factor / genetics*
  • HIV-1 / immunology*
  • HeLa Cells
  • Humans
  • Immunization
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • NIH 3T3 Cells
  • T-Lymphocytes, Cytotoxic / immunology
  • Transfection
  • Vaccines, DNA / immunology*

Substances

  • AIDS Vaccines
  • Adjuvants, Immunologic
  • Codon
  • Cytokines
  • Gene Products, gag
  • Vaccines, DNA
  • Granulocyte-Macrophage Colony-Stimulating Factor